|
|
|
|
LEADER |
03072nam a22003015i 4500 |
001 |
000288335 |
005 |
20210831095845.0 |
007 |
cr nn 008mamaa |
008 |
170814s2017 xxu| s |||| 0|eng d |
020 |
|
|
|a 9781493972012
|
024 |
7 |
|
|a 10.1007/978-1-4939-7201-2
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Proteomics for Drug Discovery :
|b Methods and Protocols /
|c edited by Iulia M. Lazar, Maria Kontoyianni, Alexandru C. Lazar.
|
250 |
|
|
|a 1st ed. 2017.
|
260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Humana,
|c 2017.
|
300 |
|
|
|a XI, 302 p. 62 illus., 46 illus. in color. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Methods in Molecular Biology,
|v 1647
|
505 |
0 |
|
|a A Photoaffinity Labeling-Based Chemoproteomics Strategy for Unbiased Target Deconvolution of Small Molecule Drug Candidates -- Multiplexed Liquid Chromatography-Multiple Reaction Monitoring Mass Spectrometry Quantification of Cancer Signaling Proteins -- Monitoring Dynamic Changes of the Cell Surface Glycoproteome by Quantitative Proteomics -- High Resolution Parallel Reaction Monitoring with Electron Transfer Dissociation for Middle-Down Proteomics: An Application to Study the Quantitative Changes Induced by Histone Modifying Enzyme Inhibitors and Activators -- Preparation and Immunoaffinity Depletion of Fresh Frozen Tissue Homogenates for Mass Spectrometry-Based Proteomics in the Context of Drug Target/Biomarker Discovery -- Target Identification Using Cell Permeable and Cleavable Chloroalkane Derivatized Small Molecules -- Microfluidics-Mass Spectrometry of Protein-Carbohydrate Interactions: Applications to Development of Therapeutics and Biomarker Discovery -- Studying Protein-Protein Interactions by Biotin AP-Tagged Pulldown and LTQ-Orbitrap Mass Spectrometry -- Post-Translational Modification Profiling-Functional Proteomics for the Analysis of Immune Regulation -- Reverse Phase Protein Arrays and Drug Discovery -- Probing Protein Kinase-ATP Interactions Using a Fluorescent ATP Analog -- Preparation of Disease-Related Protein Assemblies for Single Particle Electron Microscopy -- Identification of Lipid-Binding Modulators Using the Protein-Lipid Overlay Assay -- Resazurin Live Cell Assay: Setup and Fine-Tuning for Reliable Cytotoxicity -- Exploring Protein-Protein Interactions as Drug Targets for Anti-Cancer Therapy with In Silico Workflows -- Method to Identify Silent Codon Mutations that May Alter Peptide Elongation Kinetics and Co-Translational Protein Folding -- In Silico Design of Anticancer Peptides -- Docking and Virtual Screening in Drug Discovery -- Bioinformatics Resources for Interpreting Proteomics Mass Spectrometry Data.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
700 |
1 |
|
|a Lazar, Iulia M.
|e editor.
|
700 |
1 |
|
|a Kontoyianni, Maria.
|e editor.
|
700 |
1 |
|
|a Lazar, Alexandru C.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|